T. Rowe Price Associates’s Diebold Nixdorf Incorporated DBD Stock Holding History

T. Rowe Price Associates’s Portfolio DBD Stock Details DBD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-14,210	Closed	-$18K	–	3007
2023 Q1	$18K	Sell	14,210 -15,883	-53%	-$35.3K	﹤0.01%	2865
2022 Q4	$43K	Sell	30,093 -29,800	-50%	-$63.9K	﹤0.01%	2831
2022 Q3	$147K	Buy	59,893 +5,552	+10%	+$18.5K	﹤0.01%	2632
2022 Q2	$123K	Buy	54,341 +18,100	+50%	+$67.4K	﹤0.01%	2718
2022 Q1	$244K	Buy	36,241 +11,779	+48%	+$101K	﹤0.01%	2640
2021 Q4	$221K	Sell	24,462 -1,300	-5%	-$12.1K	﹤0.01%	2719
2021 Q3	$260K	Buy	25,762 +100	+0.4%	+$1.1K	﹤0.01%	2628
2021 Q2	$330K	Buy	25,662 +4,557	+22%	+$62.5K	﹤0.01%	2557
2021 Q1	$298K	Buy	21,105 +2,650	+14%	+$36.5K	﹤0.01%	2570
2020 Q4	$197K	Buy	+18,455	New	+$168K	﹤0.01%	2558
2020 Q3	–	Sell	-15,365	Closed	-$93K	–	2640
2020 Q2	$93K	Sell	15,365 -19,167	-56%	-$94.6K	﹤0.01%	2436
2020 Q1	$122K	Sell	34,532 -714	-2%	-$6.05K	﹤0.01%	2391
2019 Q4	$372K	Buy	35,246 +3,043	+9%	+$27K	﹤0.01%	2256
2019 Q3	$361K	Sell	32,203 -7,876	-20%	-$93.3K	﹤0.01%	2222
2019 Q2	$367K	Buy	40,079 +100	+0.3%	+$1.04K	﹤0.01%	2239
2019 Q1	$443K	Sell	39,979 -36,700	-48%	-$257K	﹤0.01%	2163
2018 Q4	$191K	Sell	76,679 -1,111	-1%	-$3.98K	﹤0.01%	2418
2018 Q3	$350K	Buy	77,790 +34,858	+81%	+$254K	﹤0.01%	2295
2018 Q2	$513K	Buy	42,932 +83	+0.2%	+$1.11K	﹤0.01%	2130
2018 Q1	$660K	Buy	42,849 +147	+0.3%	+$2.46K	﹤0.01%	1976
2017 Q4	$698K	Sell	42,702 -23,028	-35%	-$445K	﹤0.01%	1948
2017 Q3	$1.5M	Buy	65,730 +17,928	+38%	+$382K	﹤0.01%	1637
2017 Q2	$1.34M	Buy	47,802 +822	+2%	+$22.7K	﹤0.01%	1673
2017 Q1	$1.44M	Sell	46,980 -6,700	-12%	-$189K	﹤0.01%	1664
2016 Q4	$1.35M	Hold	53,680	–	–	﹤0.01%	1674
2016 Q3	$1.33M	Buy	53,680 +17,320	+48%	+$460K	﹤0.01%	1645
2016 Q2	$903K	Hold	36,360	–	–	﹤0.01%	1744
2016 Q1	$1.05M	Buy	36,360 +3,100	+9%	+$81K	﹤0.01%	1689
2015 Q4	$1M	Buy	33,260 +2,270	+7%	+$77.1K	﹤0.01%	1689
2015 Q3	$923K	Hold	30,990	–	–	﹤0.01%	1733
2015 Q2	$1.08M	Hold	30,990	–	–	﹤0.01%	1725
2015 Q1	$1.1M	Hold	30,990	–	–	﹤0.01%	1702
2014 Q4	$1.07M	Buy	30,990 +2,800	+10%	+$98.7K	﹤0.01%	1703
2014 Q3	$996K	Hold	28,190	–	–	﹤0.01%	1729
2014 Q2	$1.13M	Hold	28,190	–	–	﹤0.01%	1704
2014 Q1	$1.12M	Hold	28,190	–	–	﹤0.01%	1669
2013 Q4	$931K	Buy	28,190 +2,600	+10%	+$81.1K	﹤0.01%	1694
2013 Q3	$751K	Hold	25,590	–	–	﹤0.01%	1751
2013 Q2	$862K	Buy	+25,590	New	+$792K	﹤0.01%	1693

Other funds holding DBD

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Public Employees Retirement Association of Colorado Denver, Colorado $25.5B AUM 28.85% 1-Year Est. Return

BFIM

Beese Fulmer Investment Management Canton, Ohio $1.56B AUM 26.01% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

T. Rowe Price Associates's DBD Position: Q2 2023 in Review

T. Rowe Price Associates sold out of Diebold Nixdorf Incorporated (DBD) in Q2 2023, closing a stake of 14,210 shares — an estimated $18K sold.

T. Rowe Price Associates first reported a position in DBD in Q2 2013 and held it in 39 quarters. The position peaked at $1.5M in Q3 2017. 7 funds tracked by Wall St. Rank hold DBD as of Q2 2023.

T. Rowe Price Associates reported no remaining Diebold Nixdorf Incorporated position as of Q2 2023 after selling out during the quarter.
T. Rowe Price Associates sold 14,210 Diebold Nixdorf Incorporated shares in Q2 2023, an estimated $18K.
T. Rowe Price Associates first reported a position in Diebold Nixdorf Incorporated in Q2 2013 and held it in 39 quarters.
T. Rowe Price Associates's Diebold Nixdorf Incorporated position peaked at $1.5M in Q3 2017.
7 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q2 2023.

Based on T. Rowe Price Associates's 13F filing for Q2 2023, filed 14 Aug 2023.